Clinica's Medtech Ventures - Issue 14: CoreValve's ReValving technology holds promise for risky heart valve patients
This article was originally published in Clinica
Executive Summary
Company: CoreValve Specialty area(s): Percutaneous aortic valve replacement (PAVR) and transapical aortic valve replacement (TAVR) Based in: Irvine, California, US Founded in: 2001 No. of employees: 50 Total investment received to date: $65m from Maverick Capital, Sofinnova Partners, Apax Partners and HealthCap
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.